Amyloidosis and Lung Cancer

Clinical systemic amyloidosis has been rarely described in patients with lung cancer. A new case of such an association is described with a review of the literature and a discussion about the possible biological mechanisms responsible for the development of systemic amyloidosis in patients with lung...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Clinical lung cancer 2003-01, Vol.4 (4), p.249-251
Hauptverfasser:	Barceló, J. Ramón, Muñoz, Alberto, Mañé, Joan M., Rubio, Itziar, Pérez-Hoyos, Teresa, Viteri, Ainhoa, López-Vivanco, Guillermo M.
Format:	Artikel
Sprache:	eng
Schlagworte:	AA amyloid Acquired systemic amyloidosis non–small-cell lung cancer Serum AA amyloid
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Clinical systemic amyloidosis has been rarely described in patients with lung cancer. A new case of such an association is described with a review of the literature and a discussion about the possible biological mechanisms responsible for the development of systemic amyloidosis in patients with lung cancer. Circulating precursors of amyloid fibrils in patients with lung cancer might be implicated more than expected in the biology of tumoral disease.
ISSN:	1525-7304 1938-0690
DOI:	10.3816/CLC.2003.n.006